Gonadal vein leiomyosarcoma, from clinical practice to a literature review: surgical, oncological and histopathologic correlation

Gonadal vein leiomyosarcoma, from clinical practice to a literature review: surgical, oncological and histopathologic correlation

Authors

  • Giusy Carmen Imbriani Department of Surgery, Referral Cancer Center of Basilicata, Scientific Institute for Hospitalization and Care, Rionero in Vulture (Potenza) – Italy
  • Giuseppe Guarro b- Translational Medical and Surgical Sciences, PhD Program, University of Parma (Parma) – Italy https://orcid.org/0000-0003-2156-4553
  • Massimo Dante Di Somma Department of Pathological Anatomy, Referral Cancer Center of Basilicata, Scientific Institute for Hospitalization and Care, Rionero in Vulture (Potenza) – Italy
  • Italo Sarno Department of Oncology, Referral Cancer Center of Basilicata, Scientific Institute for Hospitalization and Care, Rionero in Vulture (Potenza) – Italy
  • Raffaele Ardito Department of Oncology, Referral Cancer Center of Basilicata, Scientific Institute for Hospitalization and Care, Rionero in Vulture (Potenza) – Italy
  • Manuela Botte Department of Radiology, Referral Cancer Center of Basilicata, Scientific Institute for Hospitalization and Care, Rionero in Vulture (Potenza) – Italy
  • Tommaso Fabrizio Department of Plastic Surgery, Referral Cancer Center of Basilicata, Scientific Institute for Hospitalization and Care, Rionero in Vulture (Potenza) – Italy
  • Dario Scala Department of Surgery, Referral Cancer Center of Basilicata, Scientific Institute for Hospitalization and Care, Rionero in Vulture (Potenza) – Italy

Keywords:

leiomyosarcoma, retroperitoneal space, tumor of gonadal vein

Abstract

Background and aim:Vascular leiomyosarcomas are rare and generally originate from the muscular wall of the inferior vena cava. Leiomyosarcomas originating from the wall of the gonadal veins are rare and just about ten cases are described in literature. In the present paper, we have described a case of a LMS originating from the left gonadal vein.

Methods:A 44-year-old woman presented in March 2020 pain symptoms at the level of the left renal lodge. The subsequent CT and the biopsy confirmed the diagnosis of G2 grade LMS. The mass was then removed en bloc from the posterior and inferior pancreatic plane, from the aortic plane and from the retroperitoneal plane, post chemoteraphy.

Results:Pathologic report revealed a typical leiomyosarcoma, moderately differentiated G2 with minor dedifferentiated areas of pleomorphic leiomyosarcoma.

Conclusions:The LMSs originating from gonadal veins represent an uncommon oncologic challenge. The radical en bloc excision represents the therapeutic gold standard.

 

References

Cho HJ, Kim HK, Suh JH, Lee GJ, Shim JC, Kim YH, Lee HS, Kang YK. Leiomyosarcoma of the ovarian vein: a case report with radiological findings. Korean J Radiol. 2008 Jul;9 Suppl(Suppl):S14-7. doi: 10.3348/kjr.2008.9.s.s14..

Saigusa S, Ohi M, Inoue Y, Kusunoki M. Preoperative diagnosis by three-dimensional angiography of a leiomyosarcoma arising from the left ovarian vein. BMJ Case Rep. 2013 Apr 16;2013:bcr2013008823. doi: 10.1136/bcr-2013-008823.

Rajpurohit V, Mehta P, Kothari N, Nathani S. Leiomyosarcoma of the Right Ovarian Vein: a Case Report with Multimodality Management and Long-Term Follow-Up. Indian J Surg Oncol. 2019 Sep;10(3):523-526. doi: 10.1007/s13193-019-00936-3. Epub 2019 May 31.

Matsuzono T, Chan CY, Chan MY. Gonadal vein leiomyosarcoma: A case report with radiological findings. Intractable Rare Dis Res. 2015 Aug;4(3):152-4. doi: 10.5582/irdr.2015.01016.

Von Mehren M, Kane JM, Bui MM, et al. NCCN Guidelines Insights: Soft Tissue Sarcoma, Version 1.2021. J Natl Compr Canc Netw. 2020 Dec 2;18(12):1604-1612. doi: 10.6004/jnccn.2020.0058.

Tsuyoshi H., Yoshida Y., Kurokawa T., Kotsuji F. Diagnosis and management of leiomyosarcoma arising from ovarian vein: case report and literature review. The Journal of Obstetrics and Gynaecology Research. 2012;38(2):466–470. doi: 10.1111/j.1447-0756.2011.01725.x.

Alkhalili E., Greenbaum A., Langsfeld M., et al. Leiomyosarcoma of the inferior vena cava: a case series and review of the literature. Annals of Vascular Surgery. 2016;33:245–251. doi: 10.1016/j.avsg.2015.10.016.

De la Fuente N, Rodríguez Blanco M, Cerdán G, Moral A, Artigas V. Leiomyosarcoma of the Right Gonadal Vein: Review of the Approach and Prognostic in a Rare Case. Case Rep Surg. 2019 Jan 22;2019:4042689. doi: 10.1155/2019/4042689.

Hirano T, Okumura H, Maeda S, Shimada M, Imakiire A, Makisumi K, Higashi M, Natsugoe S. Vascular leiomyosarcoma originating from the right ovarian vein: a case report and literature review. Surg Case Rep. 2019 Jul 24;5(1):120. doi: 10.1186/s40792-019-0679-5.

Albertsmeier M, Rauch A, Roeder F, Hasenhütl S, Pratschke S, Kirschneck M, et al. External beam radiation therapy for resectable soft tissue sarcoma: a systematic review and meta-analysis. Ann Surg Oncol. 2018;25:754–767. doi: 10.1245/s10434-017-6081-2.

Dalainas I. Vascular smooth muscle tumors: review of the literature. International Journal of Surgery. 2008;6(2):157–163. doi: 10.1016/j.ijsu.2007.03.004.

Pasquali S, Gronchi A. Neoadjuvant chemotherapy in soft tissue sarcomas: latest evidence and clinical implications. Ther Adv Med Oncol. 2017;9:415–429. doi: 10.1177/1758834017705588

Movva S, von Mehren M, Ross EA, Handorf E. Patterns of chemotherapy administration in high‐risk soft tissue sarcoma and impact on overall survival. J Natl Compr Canc Netw. 2015; 13: 1366‐ 1374

Almond LM, Gronchi A, Strauss D, Jafri M, Ford S, Desai A. Neoadjuvant and adjuvant strategies in retroperitoneal sarcoma. Eur J Surg Oncol. 2018; 44: 571‐ 579

Constantinidou A, Jones RL. Systemic therapy in retroperitoneal sarcoma management. J Surg Oncol. 2018; 117: 87‐ 92.

Italiano A, Toulmonde M, Cioffi A, et al. Advanced well‐differentiated/dedifferentiated liposarcomas: role of chemotherapy and survival. Ann Oncol. 2012; 23: 1601‐ 1607

Livingston JA, Bugano D, Barbo A, et al. Role of chemotherapy in dedifferentiated liposarcoma of the retroperitoneum: defining the benefit and challenges of the standard. Sci Rep. 2017; 7: 11836

D'Ambrosio L, Touati N, Blay JY, et al. Doxorubicin plus dacarbazine, doxorubicin plus ifosfamide, or doxorubicin alone as a first‐line treatment for advanced leiomyosarcoma: a propensity score matching analysis from the European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group. Cancer. 2020; 126: 2637‐ 2647

Yang SH, Chien JC, Chen CL, Chan WP. Leiomyosarcoma of ovarian vein compression as a cause of hydronephrosis. Eur J Gynaecol Oncol. 2011;32(3):336-8.

Downloads

Published

14-04-2023

Issue

Section

Case Reports: Oncology and Hematology

How to Cite

1.
Imbriani GC, Guarro G, Di Somma MD, et al. Gonadal vein leiomyosarcoma, from clinical practice to a literature review: surgical, oncological and histopathologic correlation. Acta Biomed. 2023;94(S1):e2023129. doi:10.23750/abm.v94iS1.14107